Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. Sep 14, 2022; 28(34): 5023-5035
Published online Sep 14, 2022. doi: 10.3748/wjg.v28.i34.5023
Table 5 Risk factors associated with fetal negative outcomes
Clinical variables
Case/exposed1
Crude OR (95%CI)
Adjusted OR (95%CI)
Head circumference ≤ 33 cm at birth
Maternal age, n (%)
< 35118 /194 (60.8)11
≥ 3518 /194 (9.3)1.1 (0.4-2.8); P = 0.822.0 (0.7-5.7); P = 0.19
Nulliparity, n (%)
No53/194 (27.3)11
Yes83 /194 (42.8)1.9 (1.0-3.6); P = 0.042.4 (1.2-4.9); P = 0.01
BMI, n (%)
< 30120/194 (61.9)11
≥ 3016/194 (8.2)0.4 (0.2-0.8); P = 0.0080.3 (0.1-0.7); P = 0.003
HCV infection, n (%)
No75/194 (38.7)11
Yes61/194 (31.4)1.8 (0.9-3.5); P = 0.082.1 (1.1-4.3); P = 0.03
Intertuberous diameter, n (%)
≥ 8.585/194 (43.8)11
< 8.551/194 (26.3)1.1 (0.6-2.0); P = 0.861.0 (0.5-2.0); P = 0.75
Weight at birth ≤ 3250 gms
Age, n (%)
< 3588/194 (45.4)11
≥ 3513/194 (6.7)1.0 (0.4-2.3); P > 0.991.7 (0.6-4.3); P = 0.29
Nulliparity, n (%)
No39/194 (20.1)11
Yes62/194 (32.0)1.6 (0.9-2.8); P = 0.131.8 (0.9-3.4); P = 0.07
BMI, n (%)
< 3088/194 (45.4)11
≥ 3013 /194 (6.7)0.6 (0.3-1.2); P = 0.160.5 (0.2-1.1); P = 0.09
HCV infection HCV, n (%)
No52/194 (26.8)11
Yes49/194 (25.3)2.0 (1.1-3.5); P = 0.022.2 (1.2-4.0); P = 0.01
Intertuberous diameter, n (%)
≥ 8.561/194 (31.4)11
< 8.540/194 (20.6)1.2 (0.7-2.2); P = 0.461.1 (0.6-2.1); P = 0.66